Nations Financial Group Inc. IA ADV raised its stake in shares of UiPath Inc. (NYSE:PATH – Free Report) by 6.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 26,090 shares of the healthcare company’s stock after purchasing an additional 1,654 shares during the period. Nations Financial Group Inc. IA ADV’s holdings in UiPath were worth $334,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in PATH. Future Financial Wealth Managment LLC bought a new position in shares of UiPath during the 3rd quarter valued at about $26,000. JTC Employer Solutions Trustee Ltd bought a new position in shares of UiPath in the 3rd quarter valued at about $26,000. Hantz Financial Services Inc. bought a new position in shares of UiPath in the 2nd quarter valued at about $28,000. Redwood Wealth Management Group LLC bought a new position in shares of UiPath in the 2nd quarter valued at about $43,000. Finally, Allspring Global Investments Holdings LLC lifted its holdings in shares of UiPath by 124.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 4,098 shares of the healthcare company’s stock valued at $52,000 after acquiring an additional 2,274 shares during the last quarter. Institutional investors own 62.50% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages recently commented on PATH. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $16.00 price target on shares of UiPath in a report on Friday, September 6th. DA Davidson increased their price target on shares of UiPath from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Evercore ISI increased their price target on shares of UiPath from $13.00 to $16.00 and gave the company an “in-line” rating in a report on Friday, September 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a report on Wednesday, October 23rd. Finally, Barclays increased their price objective on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research report on Friday, September 6th. Sixteen equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, UiPath presently has a consensus rating of “Hold” and a consensus target price of $17.47.
Insider Activity
In other UiPath news, CFO Ashim Gupta sold 47,671 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the sale, the chief financial officer now directly owns 849,917 shares in the company, valued at $10,258,498.19. This trade represents a 5.31 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 22.37% of the company’s stock.
UiPath Stock Performance
Shares of NYSE:PATH opened at $12.63 on Friday. The firm has a market cap of $6.95 billion, a PE ratio of -63.15 and a beta of 0.87. The firm’s 50 day simple moving average is $12.60 and its 200-day simple moving average is $13.47. UiPath Inc. has a one year low of $10.37 and a one year high of $27.87.
UiPath (NYSE:PATH – Get Free Report) last released its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The firm had revenue of $316.00 million for the quarter, compared to the consensus estimate of $303.69 million. During the same period last year, the firm earned ($0.09) earnings per share. The company’s quarterly revenue was up 10.0% on a year-over-year basis. Equities research analysts predict that UiPath Inc. will post -0.23 EPS for the current fiscal year.
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
See Also
- Five stocks we like better than UiPath
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- The Most Important Warren Buffett Stock for Investors: His Own
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What is a Special Dividend?
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.